首页 > 市场调查报告书 > 医疗设备

生技设备

空间体学市场规模、份额和成长分析（按技术、产品、工作流程、样本类型、最终用途和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1898613

空间体学市场规模、份额和成长分析（按技术、产品、工作流程、样本类型、最终用途和地区划分）－2026-2033年产业预测

Spatial Omics Market Size, Share, and Growth Analysis, By Technology (Spatial Transcriptomics, Spatial Genomics), By Product (Instruments, Consumables), By Workflow, By Sample Type, By End-use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月25日 | 出版商:

SkyQuest | 英文 242 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，全球空间体学市场规模将达到 4029.6 亿美元，到 2025 年将达到 4,448.7 亿美元，到 2033 年将达到 9,817.1 亿美元，预测期（2026-2033 年）的复合年增长率为 10.4%。

全球空间体学市场正经历强劲成长，这主要得益于定序技术的进步、创新研究投入的增加以及遗传疾病发生率的上升。从基因定序转向透过空间表型分析细胞类型和生物标记相互作用是这一发展过程中的关键一步。市场上的主要企业提供多样化的解决方案，能够定量分析约1800个RNA靶标，有效地将组织内的分子分析与空间细胞背景结合。这种空间基因组资讯已被证明在疾病诊断中至关重要，因为它可作为识别病理状况的生物标记。此外，这项技术正在加深我们对关键生物学过程（例如组织结构和细胞调控）的理解，从而改变我们治疗和管理疾病的方法。

全球空间体学市场驱动因素

随着人们寻求了解和识别那些常常代代相传的遗传疾病，全球对空间体学工具的需求正在激增。这一趋势的驱动力在于人们渴望揭开遗传疾病及其潜在机制的不确定性。随着越来越多的人意识到渗透技术在诊断和研究这些疾病方面的潜在优势，人们对先进的空间体学解决方案的兴趣也持续增长。因此，空间体学市场不断扩张，反映出人们越来越认识到先进技术工具在增进我们对复杂生物系统和疾病管理的理解方面所发挥的作用。

限制全球空间体学市场的因素

全球空间体学市场面临许多挑战，可能阻碍其扩张。其中一个主要阻碍因素是该新兴领域研究专长有限，这可能会扼杀创新和发展。此外，由于空间体学研究仍处于起步阶段，尚未被研究人员和从业人员广泛接受，这阻碍了其融入主流科学研究。这种知识和理解的匮乏可能会降低市场采纳率，并限制市场的整体成长潜力，因为相关人员可能不愿意投资于一个相对未知的研究领域。

全球空间体学市场趋势

全球空间体学市场正经历显着成长，这主要得益于对能够更深入了解肿瘤微环境和细胞相互作用的先进诊断技术的需求不断增长。随着研究人员和医疗保健提供者认识到早期检测恶性肿瘤的重要性，空间体学正逐渐成为揭示肿瘤界面病理机制的重要工具。高通量技术与生物资讯学的融合进一步加速了空间体学的应用，使其能够对细胞图谱进行精确分析。这一趋势促进了生物技术公司与学术机构之间的合作，最终为创新治疗策略的开发和患者预后的改善铺平了道路。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争资讯

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市场趋势
公司市占率分析（2025 年）
主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较

主要企业简介

10x Genomics（US）
Illumina（US）
Fluidigm Corporation（US）
Akoya Biosciences（formerly PerkinElmer）（US）
S2 Genomics, Inc.（US）
RareCyte, Inc.（US）
ZEISS Group（Germany）
Miltenyi Biotec（Germany）
Bio-Techne Corporation（US）
Visiopharm（Denmark）
Indica Labs, Inc.（US）
Bio-Rad Laboratories, Inc.（US）
Oxford Nanopore Technologies（UK）
Takara Bio Inc.（Japan）

结论与建议

简介目录

Product Code: SQMIG35H2069

Global Spatial Omics Market size was valued at USD 402.96 Billion in 2024 and is poised to grow from USD 444.87 Billion in 2025 to USD 981.71 Billion by 2033, growing at a CAGR of 10.4% during the forecast period (2026-2033).

The global spatial omics market is experiencing robust growth driven by advancements in sequencing technology, increased investment in innovative research, and the rising incidence of genetic disorders. The shift from decoding genes to analyzing cell types and biomarker interactions through spatial phenotyping is pivotal in this evolution. Key players in the market are providing diverse solutions that facilitate the quantification of around 1,800 RNA targets, effectively merging molecular analysis with spatial cellular context within tissues. This spatial genomic information is proving vital in diagnosing diseases, as it serves as a biomarker to identify medical conditions. Moreover, this technology is enhancing our understanding of critical biological processes, such as tissue organization and cellular regulation, thereby transforming approaches to disease treatment and management.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Spatial Omics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Spatial Omics Market Segments Analysis

Global Spatial Omics Market is segmented by Technology, Product, Workflow, Sample Type, End-use and region. Based on Technology, the market is segmented into Spatial Transcriptomics, Spatial Genomics and Spatial Proteomics. Based on Product, the market is segmented into Instruments, Consumables and Software. Based on Workflow, the market is segmented into Sample Preparation, Instrumental Analysis and Data Analysis. Based on Sample Type, the market is segmented into FFPE and Fresh Frozen. Based on End-use, the market is segmented into Academic & Translational Research Institutes and Pharmaceutical & Biotechnology Companies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Spatial Omics Market

The global demand for spatial omics tools has surged as individuals seek to understand and identify genetic disorders that are often passed down through generations. This drive is fueled by the desire to clarify uncertainties surrounding hereditary diseases and their underlying mechanisms. As more people become aware of the potential benefits of osmotic technology in diagnosing and researching these conditions, the interest in sophisticated spatial omics solutions continues to grow. Consequently, the market for spatial omics is expanding, reflecting an increasing appreciation for the role of advanced technological tools in enhancing our understanding of complex biological systems and disease management.

Restraints in the Global Spatial Omics Market

The Global Spatial Omics market faces several challenges that may inhibit its expansion. A key constraint is the limited availability of research expertise in this emerging field, which can stifle innovation and development. Additionally, the nascent nature of spatial omics research leads to a lack of widespread acceptance among researchers and practitioners, creating barriers to its integration into mainstream scientific studies. This scarcity of knowledge and familiarity can slow adoption rates and limit the overall growth potential of the market, as stakeholders may be hesitant to invest in a relatively uncharted area of study.

Market Trends of the Global Spatial Omics Market

The Global Spatial Omics market is witnessing significant growth, driven by the increasing demand for advanced diagnostic techniques that enhance the understanding of tumor microenvironments and cellular interactions. As researchers and healthcare providers recognize the importance of early malignancy detection, spatial omics is emerging as a pivotal tool for elucidating pathological mechanisms at the tumor boundary. The integration of high-throughput technologies and bioinformatics further accelerates the adoption of spatial omics, facilitating precise analysis of cellular landscapes. This trend is fostering collaborations between biotechnology firms and academic institutions, ultimately paving the way for innovative therapeutic strategies and improved patient outcomes.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis
Case Study Analysis

Global Spatial Omics Market Size by Technology & CAGR (2026-2033)

Market Overview
Spatial Transcriptomics
Spatial Genomics
Spatial Proteomics

Global Spatial Omics Market Size by Product & CAGR (2026-2033)

Market Overview
Instruments
- By Mode
- Automated
- Semi-automated
- Manual
- By Type
- Sequencing Platforms
- IHC
- Microscopy
- Flow Cytometry
- Mass Spectrometry
- Others
Consumables
Software
- Bioinformatics Tools
- Imaging Tools
- Storage & Management Databases

Global Spatial Omics Market Size by Workflow & CAGR (2026-2033)

Market Overview
Sample Preparation
Instrumental Analysis
Data Analysis

Global Spatial Omics Market Size by Sample Type & CAGR (2026-2033)

Market Overview
FFPE
Fresh Frozen

Global Spatial Omics Market Size by End-use & CAGR (2026-2033)

Market Overview
Academic & Translational Research Institutes
Pharmaceutical & Biotechnology Companies

Global Spatial Omics Market Size & CAGR (2026-2033)

North America (Technology, Product, Workflow, Sample Type, End-use)
- US
- Canada
Europe (Technology, Product, Workflow, Sample Type, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Technology, Product, Workflow, Sample Type, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Technology, Product, Workflow, Sample Type, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Technology, Product, Workflow, Sample Type, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

10x Genomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fluidigm Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Akoya Biosciences (formerly PerkinElmer) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
S2 Genomics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
RareCyte, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ZEISS Group (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Miltenyi Biotec (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Techne Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Visiopharm (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Indica Labs, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Oxford Nanopore Technologies (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Takara Bio Inc. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments